Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers

Cancer Immunology Immunotherapy(2025)10.1007/s00262-025-04156-3Source: DataRank Database

Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers is a research paper published in Cancer Immunology Immunotherapy (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Samantha J. Seitter ORCID,Maria R. Parkhurst ORCID,Frank J. Lowery ORCID,M. Fukuhara ORCID,Sanghyun P. Kim ORCID

Live enrichment

PubMed:41410746 PMC:PMC12715084 OpenAlex:https://openalex.org/W4417459137

National Institutes of Health

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00262-025-04156-3.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00262-025-04156-3.pdf

publisherhttps://link.springer.com/article/10.1007/s00262-025-04156-3/fulltext.html

journalhttps://doi.org/10.1007/s00262-025-04156-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41410746

Fields of Study

PI3K/AKT/mTOR signaling in cancerT-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersHumansMutationReceptors, Antigen, T-CellHistocompatibility Antigens Class IIPhosphatidylinositol 3-KinasesFemaleMaleLymphocytes, Tumor-InfiltratingClass I Phosphatidylinositol 3-Kinases

MeSH Terms

Histocompatibility Antigens Class IIFemaleHumansMaleMutationReceptors, Antigen, T-CellLymphocytes, Tumor-InfiltratingPhosphatidylinositol 3-KinasesClass I Phosphatidylinositol 3-Kinases

Keywords

T-cell receptorHuman leukocyte antigenImmunogenicityImmunotherapyT cellIn vitroCancer immunotherapySomatic cellAntigenTCRPik3ca

Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers

FAIR Checklist

Authors (15)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)